Screening for MRSA and isolating carriers doesn’t reduce ICU infections

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3581 (Published 4 June 2013)
Cite this as: BMJ 2013;346:f3581

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

A trial randomised 43 US hospitals to one of three strategies for combating infections in intensive care units (ICUs). The first screened for meticillin resistant Staphylococcus aureus (MRSA) and isolated those who screened positive (group 1). The second added decolonisation of MRSA carriers with intranasal mupirocin and chlorhexidine bathing for five days (group 2). The third comprised decolonisation, …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL